article_metadata: Hamza Ichaoui Sonia Ben Nasr Faten Gargouri Aref Zribi Amine Hermi Sana Fendri Mehdi Balti Jihen Ayari Ramzi Khiari Issam Msakni Nada Mansouri Samir Ghozzi Abderrazek Haddaoui
article_metadata: 10.11604/pamj.2019.34.125.19421
article_metadata: Pan Afr Med J
article_metadata: 2019 Nov 1;34:125.
article_metadata: prostate hormonotherapy squamous cell carcinoma
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/33708294/
article_metadata: Adenocarcinoma / pathology Carcinoma, Squamous Cell / pathology Prostatic Neoplasms / pathology
article_metadata: Adenocarcinoma / pathology Carcinoma, Squamous Cell / pathology Prostatic Neoplasms / pathology Case Reports Adenocarcinoma / therapy Aged Antineoplastic Agents, Hormonal / administration & dosage Carcinoma, Squamous Cell / therapy Combined Modality Therapy Gonadotropin-Releasing Hormone / agonists Humans Male Neoplasm Recurrence, Local Prostatectomy Prostatic Neoplasms / therapy Triptorelin Pamoate / administration & dosage Antineoplastic Agents, Hormonal Triptorelin Pamoate Gonadotropin-Releasing Hormone
article_metadata: PMC7906544
article_metadata: 33708294
article_metadata: Transformation of a prostatic adenocarcinoma into squamous cell carcinoma after luteinizing hormone-releasing hormone (LHRH) agonist and radiotherapy treatment
article_metadata: 2019